{"id":18818,"date":"2026-02-20T16:57:47","date_gmt":"2026-02-20T15:57:47","guid":{"rendered":"https:\/\/www.aglatech14.com\/?p=18818"},"modified":"2026-02-20T16:57:47","modified_gmt":"2026-02-20T15:57:47","slug":"medical-device-regulation-mdr-revision-ivdr-eudamed-italy","status":"publish","type":"post","link":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/","title":{"rendered":"Medical Device Regulation: MDR 2025 Revision, IVDR, EUDAMED and Italian Governance"},"content":{"rendered":"<p>Medical device regulation in Europe is undergoing a significant phase of evolution, with direct impacts on the implementation of <strong>Regulation (EU) 2017\/745 (MDR)<\/strong> and <strong>Regulation (EU) 2017\/746 (IVDR)<\/strong>. Several years have now passed since the MDR and IVDR became applicable; however, while the European regulatory system can no longer be considered in its start-up phase, it cannot yet be regarded as fully consolidated.<\/p>\n<p>Medical device manufacturers now operate in a context characterized by more stringent requirements regarding clinical evidence, post-market surveillance, traceability and data transparency. At the same time, the European Commission has launched a <strong>targeted evaluation of the MDR and IVDR<\/strong> to assess the impact of the new regulations and identify critical areas, particularly excessive complexity, costs and certification delays that threaten device availability on the market.<\/p>\n<p>In parallel, Italy is strengthening its national governance through integrated digital systems, including a new national database interoperable with <strong>EUDAMED<\/strong>. Understanding this evolution is essential to ensure compliance, operational continuity and competitiveness in the European medical device market.<\/p>\n<h3>Implementation Status of Regulation (EU) 2017\/745 (MDR) and Regulation (EU) 2017\/746 (IVDR)<\/h3>\n<p>The application of the <strong>MDR<\/strong> and <strong>IVDR<\/strong> marked one of the most significant changes in the history of European medical device regulation. Its objective was to enhance safety, increase transparency and ensure stricter control throughout the entire lifecycle of a device.<\/p>\n<p>The system has effectively raised the level of requirements, particularly regarding:<\/p>\n<ul>\n<li>clinical evidence and continuous clinical evaluation;<\/li>\n<li>post-market surveillance (PMS and PMCF);<\/li>\n<li>traceability through UDI;<\/li>\n<li>the strengthened role of notified bodies.<\/li>\n<\/ul>\n<p>However, the implementation phase has revealed <strong>operational challenges<\/strong>. The initial absence of complete implementing acts, the progressive publication of MDCG guidance documents and the not yet fully operational status of EUDAMED have, over the years, led to interpretations that are not always uniform across Member States.<\/p>\n<p>For manufacturers, the transition to the new regulatory framework has resulted in longer certification timelines, increased compliance costs and greater complexity in managing technical documentation. SMEs and legacy devices have been particularly affected during this adaptation phase.<\/p>\n<h3>Targeted Evaluation and MDR 2025 Revision<\/h3>\n<p>Pursuant to <strong>Article 121 of the MDR and Article 111 of the IVDR<\/strong>, the European Commission has initiated a <strong>targeted evaluation<\/strong> to assess the actual impact of medical device legislation.<\/p>\n<p>The analysis covers several strategic aspects: system sustainability, availability of devices on the European market, impact on innovation and competitiveness, as well as critical issues emerging in the post-market phase.<\/p>\n<p>The MDR revision proposal, presented on 16 December 2025, may introduce specific corrective measures aimed at improving system efficiency without altering its overall structure. For manufacturers, this means operating within a dynamic framework in which compliance is not a static milestone but a continuous process of updating and adaptation.<\/p>\n<p>Monitoring regulatory developments therefore becomes an essential component of corporate strategy.<\/p>\n<h3>EUDAMED and UDI: The Digital Core of European Regulation<\/h3>\n<p>Within the new medical device governance framework, <strong>EUDAMED<\/strong> represents the central digital infrastructure. The European database, whose full functionality is expected in 2026, is designed to integrate device registration, vigilance, certifications and economic information.<\/p>\n<p>The <strong>Unique Device Identification (UDI)<\/strong> system becomes the primary traceability key, allowing each device to be uniquely linked to its technical documentation, vigilance reports and data uploaded to the system.<\/p>\n<p>For manufacturers, managing data in EUDAMED cannot be considered merely an administrative obligation. Consistency between technical documentation, the declaration of conformity, labelling and the information entered into the database is now a critical compliance element.<\/p>\n<p>In an increasingly transparent and interconnected system, inconsistencies may generate clarification requests, observations from competent authorities or issues during audits.<\/p>\n<h3>Medical Devices in Italy: National Database 2.0 and Integrated Governance<\/h3>\n<p>In Italy, we are witnessing a strengthening of national governance.\u00a0The future <strong>National Database 2.0<\/strong> will be interoperable with EUDAMED and will integrate regulatory data, consumption flows, public contracts and economic information. This model will enable institutions to enhance their monitoring and market analysis capabilities, including through advanced data processing tools.<\/p>\n<p><strong>Device vigilance<\/strong> (the post-market surveillance system for medical devices) is also playing an increasingly central role. The rise in reports in recent years and the digitalization of management systems confirm that the post-market phase is now an integral part of the regulatory framework. The manufacturer\u2019s responsibility extends throughout the entire lifecycle of the device and requires structured and well-documented PMS and PMCF processes.<\/p>\n<h3>Medical Device Translations and MDR Language Requirements<\/h3>\n<p>An often underestimated aspect of European medical device legislation concerns <a href=\"https:\/\/www.aglatech14.com\/en\/translating-documents-relating-to-medical-devices\/\"><strong>medical device translations<\/strong><\/a>, particularly <strong>MDR and IVDR translations<\/strong> of technical documentation, <strong>IFUs<\/strong> and <strong>labelling<\/strong>, as well as compliance with language requirements in the various Member States.<\/p>\n<p>Instructions for use (IFUs), labels and documentation intended for authorities must be drafted in the official languages required by the target market. A translation that is inconsistent with the technical dossier or the approved version may generate significant non-conformities or issues during market placement.<\/p>\n<p>Under the MDR and IVDR framework, linguistic quality is closely linked to device safety. Clinical terminology, indications for use, warnings and contraindications must be translated with absolute precision, maintaining full consistency with the technical documentation and the data recorded in EUDAMED.<\/p>\n<p>With the digitalization of processes, including electronic IFUs and uploads to European systems, multilingual management must be integrated into the company\u2019s quality system. Translations must become an integral part of medical device compliance.<\/p>\n<h3>Medical Device Compliance: An Integrated Approach<\/h3>\n<p>The evolution of medical device regulation in Europe and Italy highlights a clear trend: greater integration between regulation, digital data, vigilance and economic governance.\u00a0For manufacturers, this means adopting an <strong>integrated approach<\/strong> that includes:<\/p>\n<ul>\n<li>continuous monitoring of MDR and IVDR developments;<\/li>\n<li>structured data management in EUDAMED;<\/li>\n<li>strengthening of post-market systems;<\/li>\n<li>rigorous control of documentary consistency;<\/li>\n<li>integration of translations into the quality system.<\/li>\n<\/ul>\n<p>Compliance is no longer an activity limited to the certification phase but a cross-functional process involving regulatory, quality, clinical and linguistic functions.<\/p>\n<p>In a transforming regulatory environment, the ability to correctly interpret European and Italian medical device legislation and translate it into coherent corporate processes represents a decisive factor for operating successfully and sustainably in the medical device market.<\/p>\n<p>&nbsp;<\/p>\n<p><em>Aglatech14 ContenTalkers<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medical device regulation in Europe is undergoing a significant phase of evolution, with direct impacts on the implementation of Regulation (EU) 2017\/745 (MDR) and Regulation (EU) 2017\/746 (IVDR). Several years have now passed since the MDR and IVDR became applicable; however, while the European regulatory system can no longer be considered in its start-up phase, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":18817,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71,1,77],"tags":[],"class_list":["post-18818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-legal-translations","category-scientific-medical-translations"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medical Device Regulation: MDR, IVDR, EUDAMED<\/title>\n<meta name=\"description\" content=\"Medical device regulation: MDR 2025 revision, IVDR 2017\/746, EUDAMED and the Italian national database. Concrete impacts for manufacturers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical Device Regulation: MDR, IVDR, EUDAMED\" \/>\n<meta property=\"og:description\" content=\"Medical device regulation: MDR 2025 revision, IVDR 2017\/746, EUDAMED and the Italian national database. Concrete impacts for manufacturers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/\" \/>\n<meta property=\"og:site_name\" content=\"Aglatech14\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Aglatech14TraduzioniProfessionali\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-20T15:57:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/02\/MDR-2-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"llegnani\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"llegnani\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/\"},\"author\":{\"name\":\"llegnani\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/person\\\/1026354103020700e41439c85bf5335d\"},\"headline\":\"Medical Device Regulation: MDR 2025 Revision, IVDR, EUDAMED and Italian Governance\",\"datePublished\":\"2026-02-20T15:57:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/\"},\"wordCount\":1002,\"publisher\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/MDR-2-scaled.jpg\",\"articleSection\":[\"Articles\",\"Legal translations\",\"Scientific medical translations\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/\",\"name\":\"Medical Device Regulation: MDR, IVDR, EUDAMED\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/MDR-2-scaled.jpg\",\"datePublished\":\"2026-02-20T15:57:47+00:00\",\"description\":\"Medical device regulation: MDR 2025 revision, IVDR 2017\\\/746, EUDAMED and the Italian national database. Concrete impacts for manufacturers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/MDR-2-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/MDR-2-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"Normativa dispositivi medici: MDR, IVDR e EUDAMED\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medical Device Regulation: MDR 2025 Revision, IVDR, EUDAMED and Italian Governance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/\",\"name\":\"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali\",\"description\":\"Societ\u00e0 di traduzioni professionali e traduzioni tecniche\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#organization\",\"name\":\"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_aglatech14_agenzia_traduzioni_milano.png\",\"contentUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_aglatech14_agenzia_traduzioni_milano.png\",\"width\":1602,\"height\":1595,\"caption\":\"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Aglatech14TraduzioniProfessionali\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/aglatech14\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/person\\\/1026354103020700e41439c85bf5335d\",\"name\":\"llegnani\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g\",\"caption\":\"llegnani\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical Device Regulation: MDR, IVDR, EUDAMED","description":"Medical device regulation: MDR 2025 revision, IVDR 2017\/746, EUDAMED and the Italian national database. Concrete impacts for manufacturers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/","og_locale":"en_US","og_type":"article","og_title":"Medical Device Regulation: MDR, IVDR, EUDAMED","og_description":"Medical device regulation: MDR 2025 revision, IVDR 2017\/746, EUDAMED and the Italian national database. Concrete impacts for manufacturers.","og_url":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/","og_site_name":"Aglatech14","article_publisher":"https:\/\/www.facebook.com\/Aglatech14TraduzioniProfessionali","article_published_time":"2026-02-20T15:57:47+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/02\/MDR-2-scaled.jpg","type":"image\/jpeg"}],"author":"llegnani","twitter_card":"summary_large_image","twitter_misc":{"Written by":"llegnani","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#article","isPartOf":{"@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/"},"author":{"name":"llegnani","@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/person\/1026354103020700e41439c85bf5335d"},"headline":"Medical Device Regulation: MDR 2025 Revision, IVDR, EUDAMED and Italian Governance","datePublished":"2026-02-20T15:57:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/"},"wordCount":1002,"publisher":{"@id":"https:\/\/www.aglatech14.com\/en\/#organization"},"image":{"@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/02\/MDR-2-scaled.jpg","articleSection":["Articles","Legal translations","Scientific medical translations"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/","url":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/","name":"Medical Device Regulation: MDR, IVDR, EUDAMED","isPartOf":{"@id":"https:\/\/www.aglatech14.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#primaryimage"},"image":{"@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/02\/MDR-2-scaled.jpg","datePublished":"2026-02-20T15:57:47+00:00","description":"Medical device regulation: MDR 2025 revision, IVDR 2017\/746, EUDAMED and the Italian national database. Concrete impacts for manufacturers.","breadcrumb":{"@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#primaryimage","url":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/02\/MDR-2-scaled.jpg","contentUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/02\/MDR-2-scaled.jpg","width":2560,"height":1707,"caption":"Normativa dispositivi medici: MDR, IVDR e EUDAMED"},{"@type":"BreadcrumbList","@id":"https:\/\/www.aglatech14.com\/en\/medical-device-regulation-mdr-revision-ivdr-eudamed-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aglatech14.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medical Device Regulation: MDR 2025 Revision, IVDR, EUDAMED and Italian Governance"}]},{"@type":"WebSite","@id":"https:\/\/www.aglatech14.com\/en\/#website","url":"https:\/\/www.aglatech14.com\/en\/","name":"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali","description":"Societ\u00e0 di traduzioni professionali e traduzioni tecniche","publisher":{"@id":"https:\/\/www.aglatech14.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aglatech14.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.aglatech14.com\/en\/#organization","name":"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali","url":"https:\/\/www.aglatech14.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2025\/03\/logo_aglatech14_agenzia_traduzioni_milano.png","contentUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2025\/03\/logo_aglatech14_agenzia_traduzioni_milano.png","width":1602,"height":1595,"caption":"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali"},"image":{"@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Aglatech14TraduzioniProfessionali","https:\/\/www.linkedin.com\/company\/aglatech14\/"]},{"@type":"Person","@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/person\/1026354103020700e41439c85bf5335d","name":"llegnani","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g","caption":"llegnani"}}]}},"_links":{"self":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts\/18818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/comments?post=18818"}],"version-history":[{"count":4,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts\/18818\/revisions"}],"predecessor-version":[{"id":18823,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts\/18818\/revisions\/18823"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/media\/18817"}],"wp:attachment":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/media?parent=18818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/categories?post=18818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/tags?post=18818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}